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Abstract
Background: Decision aids have been overall successful in improving the quality of health decision making.
However, it is unclear whether the impact of the results of using decision aids also apply to older people (aged 65+).
We sought to systematically review randomized controlled trials (RCTs) and clinical controlled trials (CCTs) evaluating
the efficacy of decision aids as compared to usual care or alternative intervention(s) for older adults facing treatment,
screening or care decisions.
Methods: A systematic search of (1) a Cochrane review of decision aids and (2) MEDLINE, Embase, PsycINFO, Cochrane
library central registry of studies and Cinahl. We included published RCTs/CCTs of interventions designed to improve
shared decision making (SDM) by older adults (aged 65+) and RCTs/CCTs that analysed the effect of the intervention in
a subgroup with a mean age of 65+. Based on the International Patient Decision aid Standards (IPDAS), the primary
outcomes were attributes of the decision and the decision process. Other behavioral, health, and health system effects
were considered as secondary outcomes. If data could be pooled, a meta-analysis was conducted. Data for which
meta-analysis was not possible were synthesized qualitatively.
Results: The search strategy yielded 11,034 references. After abstract and full text screening, 22 papers were included.
Decision aids performed better than control resp. usual care interventions by increasing knowledge and accurate risk
perception in older people (decision attributes). With regard to decision process attributes, decision aids resulted in
lower decisional conflict and more patient participation.
Conclusions: This review shows promising results on the effectiveness of decision aids for older adults. Decision aids
improve older adults’ knowledge, increase their risk perception, decrease decisional conflict and seem to enhance
participation in SDM. It must however be noted that the body of literature on the effectiveness of decision aids for
older adults is still in its infancy. Only one decision aid was specifically developed for older adults, and the mean age in
most studies was between 65 and 70, indicating that the oldest-old were not included. Future research should expand
on the design, application and evaluation of decision aids for older, more vulnerable adults.
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Background
Medical decisions for older adults are often complex. The
evidence base to support the use of many decision support
interventions in older people is limited, especially for older
people experiencing multi-morbidity, cognitive impair-
ment or frailty as these groups have been systematically
underrepresented in randomized controlled trials (RCTs)
[1]. In addition, treatments frequently have adverse effects
in older adults. The extent to which these effects may
occur is difficult to predict in this heterogeneous popula-
tion, in particular in people with multi-morbidity who are
already on multiple medications, implying underreporting
of harms [2]. Most health decisions for older people need
to carefully view the evidence on potential harms and ben-
efits in light of decreasing life expectancy. This often in-
volves trading off quantity of life for quality of life. These
types of decisions when there is limited evidence about
outcomes, need to trade off benefits and harms and the
decision-making process needs to be highly individualized
are considered ‘preference sensitive’.
Making a decision, especially a preference sensitive one,
requires certain skills. Simplified, decision makers first
need to acquire information, then they have to identify,
understand and evaluate the different options, and finally
they need to use a suitable strategy to select the option
with the best outcome. Several papers have outlined how
age-related cognitive and affective changes may influence
these skills [3–5]. Until now, theory-based research on im-
proving decision-making in older populations is largely
missing [3]. Empirical studies have shown that, compared
with younger individuals, older adults tend to seek less in-
formation to make a decision and make decisions faster
[4, 6]. Older adults also report preferences for fewer
choice options [6], have greater difficulties in understand-
ing information about available options [7] and tend to
disproportionally focus on emotional aspects (often posi-
tive information) when making a decision [8]. Moreover,
older peoples’ preferences will vary widely depending on
for example their frailty, level of education, cognitive and
health status [9]. A systematic review found that the ma-
jority of people, including older people, prefer involve-
ment in medical decision-making [10], although a subset
of patients, usually older and less educated, prefer to dele-
gate decisions to their clinician [11].
This complex decision-making process can be sup-
ported by using decision aids. Decision aids are “intended
to help people participate in decisions that involve weigh-
ing the benefits and harms of treatment options often with
scientific uncertainty” [12, page 1]. However, existing deci-
sion aids, if theory-based [13, 14], rely on findings and evi-
dence concerning younger patients (e.g., [15–17]). While
these tools have been overall successful in enhancing the
quality of the decision making process [12, 18], it is un-
clear whether the results also apply to older adults (i.e.,
adults aged 65+), hence whether decision aids are effective
tools for this target group. Research is urgently needed to
investigate whether older patients maximally benefit from
decision aid-usage. The aim of the current study is there-
fore to find out whether the results from previous high
quality studies among people of all ages [see 12 for a re-
view] also hold for older people by conducting a system-
atic review of randomized controlled trials (RCTs) or
clinical controlled trials (CCTs) evaluating the effective-
ness of decision aids as compared to usual care and/or al-
ternative intervention(s) for older adults facing treatment,
screening or care decisions, either for themselves or for an
incapacitated significant other, on attributes of the deci-
sion and the decision process. Secondary outcomes are
behavioral, health, and health system effects.
Method
Criteria for considering studies for this review
The method used in this study was based on the Cochrane
review “Decision aids for people facing health treatment or
screening decisions” [19], from now on referred to as “the
Cochrane review”, with modifications made on the type of
participants and the type of interventions to suit our aims.
We followed an internal protocol that was written at the
start of the study.
Types of participants
We included studies that evaluated a decision aid in a
sample with a mean age of 65 years or older OR re-
ported effectiveness analysis of the decision aid in a sub-
sample of participants aged 65+ years. We included
decision aids for surrogates making a decision for an
incapacitated significant other when the mean age of
participating surrogates or the mean age of the incapaci-
tated significant others was 65+ years. We included
studies in which participants were making an actual de-
cision or a hypothetical decision.
Types of interventions
Decision aids were defined as “interventions designed to
help people make specific and deliberative choices among
options (including the status quo) by making the decision
explicit and by providing (at the minimum) information
on the options and outcomes relevant to a person’s health
status” [based on 19, page 4]. While the Cochrane re-
view [19] only included studies that evaluated decision
aids for people facing treatment or screening decisions,
we also included studies on the efficacy of decision aids
to help people make care decisions (e.g., advanced care
planning). We excluded decision aid studies focusing on:
decisions about lifestyle changes, clinical trial entry, gen-
eral advance directives, general education programs; and
decision aids to promote a recommended option.
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Types of comparisons
We included studies in which the use of a detailed decision
aid was compared with usual care, alternative interventions,
or a combination (e.g., a detailed decision aid could be
compared with usual care and with a simple decision aid).
Types of outcomes
We evaluated outcomes related to the International Pa-
tient Decision Aid Standards (IPDAS) criteria for evalu-
ating the effectiveness of decision aids [20–23].
Primary outcomes Based on the IPDAS criteria: 1) at-
tributes of the choice made: e.g., knowledge, accurate
risk perceptions and informed choice, i.e., an (intended)
decision that is based on sufficient knowledge combined
with consistent attitudes and intentions [24]; 2) attri-
butes of the decision-making process: e.g., helping the
person to recognize that a decision needs to be made,
decisional conflict, patient-provider communication, par-
ticipation in decision making, satisfaction.
Secondary outcomes Choice, adherence to chosen op-
tion, preference linked health outcomes (i.e., anxiety, worry,
caregiver burden, depression, self-efficacy, decisional re-
gret) and other health (service) outcomes mentioned.
Types of study design
We included all published studies using a RCT or CCT
design.
Search methods for identification of studies
The search method included:
(a)Searching the Cochrane review [19] for studies
published before December 2009 describing
interventions specifically developed for older people
OR studies describing analysis of the effectiveness of
decision aids in subgroups of people aged 65+.
(b)Conducting a follow-up search from 2009 onwards in
the following databases using the search strategy of the
Cochrane review as developed by Stacey et al. [19] and
retrieved from the first author: MEDLINE (OvidSP)
(December 2009-February 2014), Embase (OvidSP)
(December 2009-February 2014), PsycINFO (OvidSP)
(December 2009-February 2014), Cochrane library
central registry of studies (Whiley) (2010–2014) and
Cinahl (EBSCO HOST) (1937-February 2014). See
Additional file 1 for details of the sources searched, the
search strategies used and the number of hits retrieved.
(c)Snowball method (reference checking).
Data collection and analysis
All references were collated in Endnote and duplicate re-
cords removed. Deduplicated records were subsequently
loaded into Eppi reviewer software [25] for screening
and data extraction. The priority screening module in
Eppi reviewer [26] was used to assist the screening on
title and abstract for inclusion. In short, a random sam-
ple of records (the training set), was assessed on title
and abstract by two researchers individually (AK and
RS) and inconsistencies were discussed and resolved
with three authors (JJ, BM, JW). The abstracts were la-
beled for inclusion or exclusion for the next stage. This
training set was used for machine learning using a sup-
port vector machine (SVM) classifier to classify instances
and a class membership probability score was used to
compile a ranked list of the remaining records (see re-
sults for further explanation).
Subsequently, three authors (JJ, BM, JW) screened full
text papers and extracted data independently. The extent
to which the decision aids under investigation fulfilled
IPDAS criteria [20–22] and the risk of bias (double
coded for each included study) were also assessed, using
the Cochrane tool for judging risk of bias [27] and the
EPPI software [25]. Inconsistencies were resolved by dis-
cussion amongst three authors (JJ, BM, JW).
We conducted meta-analysis, if possible (which was
the case for knowledge, risk perception, decisional con-
flict, participation in decision making and choice). Follow-
ing the method used in the Cochrane reviews [12, 19], we
pooled results across studies in cases where: a) compar-
able outcome measures were used; b) the effects were ex-
pected to be independent of the type of decision studied;
and c) similar comparisons were used (e.g., decision aids
to usual care or detailed decision aids to simple decision
aids). To facilitate pooling of data for some outcomes (e.g.,
knowledge, decisional conflict), the scores were standard-
ized to range from 0 to 100 points [12]. We used Review
Manager 5.3.5 software (RevMan 2014) to estimate a
weighted treatment effect (with 95 % confidence inter-
vals). For continuous measures, mean differences (MD)
were used; for dichotomous outcomes, pooled relative
risks (RR) were calculated, using random-effects models.
Additional file 3 shows the results of the meta-analysis.
Data for which meta-analysis was not possible were syn-
thesized qualitatively. This was done by carefully summar-
izing the reported effects on the various outcomes per
study, comparing the effects per outcome, and drawing
conclusions about the effectiveness. Doubts about the in-
terpretation were resolved by discussion amongst four au-
thors (LH, JJ, BM, JW).
Results
Approximately 1 % of the total records identified through
database searching in the Cochrane review [19] was
assessed as potentially relevant for the current review on
the efficacy of decision aids for older people after title and
abstract screening. Using the 1 % frequency to calculate a
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sample size 1,207 records were randomly drawn from the
11,034 search results. Two reviewers independently
screened the sample set against inclusion and exclusion
criteria. In total, 25 records were identified as possibly
relevant and 1,182 records were assessed as non-relevant.
These results were subsequently used as a training set for
the SVM classifier within Eppi reviewer to produce a
ranked priority list drawn from the remaining 9,833 re-
cords. The ranked list was screened manually until the
number of relevant records identified leveled off. When
1000 consecutive records did not result in any additional
relevant citations screening was stopped. The 206 identified
records was within the 99 % confidence interval based on
extrapolation of the random sample outcome (calculated
using nQuery advisor 7.0 software). We manually screened
55 % of the total number of search results which is on the
safe upper boundary as described in Miwa et al. [26].
Taken together the 99 % CI and the high number of
screened items it was deemed appropriate to stop screen-
ing the tail. In total, 5,969 out of 10,828 excluded abstracts
were manually excluded and the remaining 4,859 were
system excluded (Fig. 1).
The Cochrane review [19] included thirteen papers
using a sample with a mean age of 65+ and one paper in
Flow Diagram of the screening process
Fig. 1 Provides the study flow diagram
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which a subgroup analysis was conducted in a sample
aged 65+ years. The additional search strategy yielded
(after having removed 2,906 duplicates) 11,034 abstracts.
After subsequent title and abstract screening, 10,828
were excluded and the full-text content of the remaining
206 papers was screened. Seven of those fulfilled all in-
clusion criteria. In addition, one paper was added using
the snowball method. Hence, the search resulted in 22
citations that fulfilled the inclusion criteria [28–49]. In
the meantime, an updated Cochrane review was pub-
lished, for which databases were searched until June
2012 [12]. When comparing the included papers in our
review (based on literature search until February 2014)
with those included in the updated Cochrane review, we
missed no papers that fulfilled our inclusion criteria.
Three [32, 39, 46] of the eight [31, 32, 36, 39, 42, 45–47]
papers that were yielded by our additional search were
also included in the updated Cochrane review.
Additional file 2 gives an overview of the characteristics
of the included papers. The 22 papers investigated the ef-
fectiveness of seventeen different decision aids using nine-
teen different samples. In six papers, the same three
decision aids were evaluated [33 resp. 48; 34 resp. 44; 40
resp. 41]. The papers of Jones et al. [33] resp. Weymiller
et al. [48] and Partin et al. [40] resp. Partin et al. [41] re-
ported on exactly the same sample. Kaner et al. [34] used
a subsample of Thomson et al. [44]. In three other pa-
pers [45–47], the same decision aid was studied, with the
explanation that the two minute verbal video narrative
[45, 46] was extended to six minutes in a later study [47].
The effectiveness was studied in three different samples
[45–47].
Thirteen of the seventeen decision aids aimed to support
a certain patient group or surrogates of patients in making
a decision: four focused on patients with atrial fibrillation
[31, 34, 35, 38, 44], two on patients with type II diabetes
[33, 36, 48], one on patients with osteoporosis [39], one
on breast cancer patients [43], one on prostate cancer pa-
tients [28] and one on people with self-reported knee pain
[30]. The decision aid of Volandes et al. [45–47] faced eld-
erly patients visiting a primary care or geriatric clinic with
the possibility of advanced dementia, and the care choice
they would like to make in that situation. In Volandes et
al. [45] the concordance between patients and their surro-
gates for end-of-life preferences was investigated. In the
other papers of Volandes et al. [46, 47] this only con-
cerned the patients’ preferences. Two decision aids aimed
to support carers or surrogates of people with dementia
[32, 42]. Four decision aids were designed to support
people in a screening decision: two were on colorectal
cancer screening [29, 49], one on breast cancer screening
[37] and one on prostate cancer screening [40, 41].
In nine studies the decision aid was delivered before a
consultation [28–31, 35, 36, 40, 41, 43], in two studies
during a consultation [34, 39, 44], in one study either be-
fore or during a consultation [33, 48], in five studies dur-
ing a special research interview [32, 45–47, 49], and in
three studies the decision aid was self-administered at
home [37, 38, 42].
Eleven of the nineteen studies established a minimum
age (‘cut-off point’) to be eligible for the study. In three
studies participants had to be 50 years or older [29, 39–41],
in two studies 60 years or older [30, 34, 44], in four studies
65 years or older [45–47, 49] and in one study they had to
be 70 or 71 years old [37]. Hanson et al. [32] included sur-
rogates of residents with advanced dementia who had to
be 65 or older. In the other eight studies [28, 31, 33, 35,
36, 38, 42, 43, 48] there was no minimum age to be eli-
gible for the study, although Fraenkel et al. [31] reported
that the decision aid was developed for older patients.
In all studies, except for Street et al. [43] and Hanson
et al. [32], the mean age of participants was 65 years or
older. In Street et al. [43], using a sample with a mean
age of 59.1, a comparison was made between older (65+),
less educated patients, and younger (<65), more educated
patients. In the study of Hanson et al. [32], the residents
with dementia were on average 85.3 years, but the mean
age of their surrogates was 59.0. In the study of Volandes
et al. [45], both the elderly persons (mean age of 83) and
their surrogates (mean age of 67.5) were on average older
than 65. The study of Stirling et al. [42] also used a sample
of carers with a mean age above 65 (i.e., 66.6), but did not
mention the age of the patients with a diagnosis of demen-
tia. Seven out of the remaining studies reported a mean
age between 65 and 70 [28, 29, 33, 35, 36, 39–41, 48];
seven other studies used a sample with a mean age be-
tween 70 and 75 [30, 34, 37, 38, 44, 46, 47, 49]. Fraenkel et
al. [31] did not report a mean age, but 56.3 % of the partic-
ipants was aged 75 or older and 21.5 % was aged between
65 and 75.
Attributes of the choice
Attributes of the choice was assessed by investigating
whether the decision aid was effective with regard to
knowledge, accuracy of risk perceptions and informed
choice. Table 1 gives a summary of the findings.
Knowledge
Thirteen papers (eleven studies) reported the effective-
ness of the intervention on knowledge. Seven studies
could be included in the meta-analysis (see Additional
file 3 and Table 1). Five studies compared decision aids
to usual care using a continuous knowledge measure-
ment. Results showed that people exposed to a decision
aid had higher average knowledge scores (MD 6.50; 95 %
CI 0.76 to 12.25). Two studies compared decision aids to
usual care using dichotomous knowledge measurements.
People using the decision aid also had higher average
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Table 1 Summary of findings attributes of the choice: results in intervention group (IG) as compared with control group (CG) (n = 15)a
Short title Knowledge Risk perception Informed choice
Fraenkel (2012) [31] More knowledge of medications for reducing stroke risk. More accurate estimates for risk of stroke and bleeding. n.m.
More knowledge of adverse effects (marginally significant).b
Hanson (2011) [32] More knowledge about dementia and feeding options.b Fewer expected benefits from tube feeding. n.m.
Jones (2009) [33] More knowledge about statins and risk for coronary events,
interacting with mode of delivery: Compared with the CG
(pamphlet), patients whose clinicians delivered the decision
aid during the office visit (IG2) showed significant more
improvements in knowledge than when a researcher
delivered the decision aid just before the office visit (IG1).
n.m. n.m.
Man-Son-Hing (1999) [35] More knowledge about stroke, atrial fibrillation, treatment
and consequences.b
More correct quantitative estimates of stroke and bleeding risk when
taking asparin or warfarin.b
n.m.
Mathers (2012) [36] More knowledge about the treatment option that is most
effective in reducing blood glucose level.b
More realistic expectations on the risk of hypoglycaemia, gaining weight
and development of complications.b
Mathieu (2007) [37] More knowledge. n.m. A greater percentage of
the IG women made an
informed choice.
McAlister (2005) [38] n.m. More realistic estimates of the potential benefits and risks of warfarin and
ASA (i.e. regarding biannual stroke risk in very-high-risk patients, RRR
and biannual bleeding risk with warfarin and ASA).
n.m.
Montori (2011) [39] More knowledge.b More likely to correctly identify the 10-year fracture risk and to identify
the estimated risk reduction with bisphosphonates.b
n.m.
Partin (2004) [40] More knowledge in both IG1 (video) and IG2 (pamphlet)
on prostate cancer natural history, treatment efficacy, and
expert disagreement (the latter was higher in IG1 as
compared to IG2).
n.m. n.m.
No more knowledge on PSA accuracy.
Partin (2006) [41] More prostate cancer screening knowledge in both IG1
(video) and IG2 (pamphlet).
n.m. n.m.
Stirling (2012) [42] More dementia knowledge according to authors
(however p = .15, possibly due to small sample size).b
n.m. n.m.
Thomson (2007) [44] Knowledge about warfarin improved in both the IG
(decision aid) and CG (guidelines) post-clinic, but declined
again in both groups by three months.
n.m. n.m.





















Table 1 Summary of findings attributes of the choice: results in intervention group (IG) as compared with control group (CG) (n = 15)a (Continued)
Volandes (2009a) [45] Knowledge scores increased for patients in both
groups post intervention; however, the changes were
higher in the IG (narrative plus video) than in the CG
(narrative-alone).
n.m. n.m.
The change in knowledge scores was also higher for
surrogates in the IG group.
Weymiller (2007) [48] IG1 and IG2 (decision aid) and CG (pamphlet) scored similarly on
knowledge.
Patients allocated to receive the interventions
from their clinician during the visit (IG2) achieved better
knowledge scores when using the decision aid than
when using the control pamphlet (IG2); this effect was
significantly greater than the effect of the decision aid vs
the control pamphlet in patients allocated to receive the
interventions from the researcher before the visit (IG1/CG1).
IG1 and IG2 (decision aid) were more likely to accurately estimate the
potential absolute risk reduction afforded by statin use than CG (pamphlet).
Patients allocated to receive the interventions from the clinicians during
the visit (IG2) were most accurate when reporting the relevant
cardiovascular risk without statins when using the decision aid than
when using the pamphlet (IG2); this effect was significantly greater than
the effect of the decision aid vs the control pamphlet in patients
allocated to receive the interventions from the researchers (IG1/CG1).
n.m.
Wolf (2000) [49] n.m. IG was able to gauge more accurately the positive FOBT predictive
value of screening for getting cancer than CG. There was no
difference in correct response rates between IG1 and IG2.
There were also significant differences between IG1, IG2 and CG in
the perceived efficacy of screening in reducing CRC mortality.
CG rated the efficacy of screening higher than IG1 (relative risk
reduction information), who rated it higher than IG2 (absolute
risk reduction information).b
n.m.
n.m. = not measured; IG = intervention group; CG = control group
aUnless otherwise stated are the described results effects in the intervention group (IG) as compared to the control group (CG); see Additional file 2 for description of the CG intervention. Standard font indicates





















knowledge scores (decision aid versus usual care pooled
RR 1.71; 95 % CI 1.33 to 2.18). Four additional studies,
described in six papers, could not be included in the
pooled outcome [33, 37, 40, 41, 45, 48]. In two of these
papers, coming from the same study [33, 48], the deci-
sion aid increased knowledge when the decision aid was
delivered by the patients’ clinician during the visit. This
effect was significantly greater than the effect in patients
who received the decision aid from the researcher be-
fore the consultation, and also greater than a control
pamphlet (either delivered by the researcher before
the consultation or by the clinician during the con-
sultation). Partin et al. [40] found a positive effect on
knowledge about prostate cancer natural history,
treatment efficacy and expert disagreement, but not
about PSA accuracy. In the other three papers, only
positive effects of using the decision aid on know-
ledge were reported [37, 41, 45].
Risk perception Eight studies assessed the effectiveness
of the intervention on risk perception. Four studies
could be included in the meta-analysis (see Additional
file 3 and Table 1). People who received a patient deci-
sion aid were more likely to have accurate risk percep-
tions than those who received usual care. The pooled
relative risk (RR) of having accurate risk perceptions was
2.27 (95 % CI 1.27 to 4.06). The other four studies re-
ported results that could not be pooled [31, 32, 38, 48].
They all found positive effects on risk perception in the
intervention group as compared to the control group
[31, 32, 38, 48]. In the study of Weymiller et al. [48], pa-
tients allocated to receive the decision aid from the clin-
ician during the visit were most accurate when reporting
the estimated 10-year cardiovasculair risk. This effect
was significantly greater than when the interventions
(experimental or control) were delivered by the re-
searcher before the consultation.
Informed choice One study measured informed choice
as an outcome. In this study, women were classified as
making an informed choice if they had adequate know-
ledge and clear values and expressed an intention to either
continue or stop mammography screening. The percent-
age of women who were able to make an informed deci-
sion to either continue or stop screening was 73 % in the
intervention group compared with 49 % in the control
group, which was a significant difference [37].
Attributes of the decision process
Findings regarding attributes of the decision process
mainly concerned decisional conflict, patient-provider
communication, participation in decision making and
satisfaction (see Table 2 for a summary).
Decisional conflict Twelve papers (eleven studies) re-
ported findings on decisional conflict, using the Decisional
Conflict Scale (DCS). This scale exists of five subscales,
i.e., ‘feeling uninformed’, ‘ineffective decision making’, ‘feel-
ing unclear about values’, ‘uncertainty’ and ‘feeling unsup-
ported’. A total score measures the construct of overall
decisional conflict [50]. A negative score indicates a de-
crease in decisional conflict, which is in favour of the IG
using the decision aid.
In eleven papers, the total score of the DCS was calcu-
lated. In the eight studies that compared decision aids to
usual care and could be pooled, the overall MD was
−3.17 out of 100 points (95 % CI −4.44 to 1.90) (see
Additional file 3 and Table 2). Of the three additional
studies that could not be pooled, one reported a signifi-
cantly positive effect [44]. The two others found no signifi-
cant findings on total decisional conflict [33, 48], although
Jones et al. [33] reported that there was less decisional
conflict when the decision aid was delivered during the
visit by the clinician, but this difference did not reach
significance.
Nine studies reported on the effectiveness of decision
aids on ‘feeling uninformed’ about options, benefits, and
harms. When the decision aid was compared to usual
care (n = 6), people exposed to the decision aid felt less
uninformed (MD −4.88, 95 % CI −6.82 to–2.94) (see
Additional file 3 and Table 2). In two of the three studies
that could not be pooled, people exposed to the decision
aid felt more informed than the CG [44, 48], but there
was no difference in the third study [42]. Weymiller et
al. [48], using the same sample as Jones et al. [33], but
reporting on subscales, found that the intervention group
felt particularly better informed when the clinician deliv-
ered the decision aid during the visit. This difference
didn’t reach significance anymore after three months.
The ‘ineffective decision making’ subscale of the DCS
was used in the same nine studies. Again, the data of six
studies comparing decision aids with usual care could be
pooled (see Additional file 3 and Table 2). Results
showed a MD of −3.12 (95 % CI −5.03 to −1.21) in
favour of the decision aid. In two out of the three add-
itional studies, no significant differences were found be-
tween the IG and the CG [42, 44]. In line with the
results on ‘feeling uninformed’, Weymiller et al. [48] re-
ported that the intervention group particularly improved
on ‘effective decision making’ when the clinician deliv-
ered the decision aid during the visit.
The ‘feeling unclear about values’ subscale of the DCS
was also reported in nine studies, six of which compared
decision aids to usual care and could be pooled (MD −3.01;
95 % CI −8.50 to 2.48) (see Additional file 3 and Table 2).
Those exposed to the decision aid in the three studies that
could not be pooled felt more clear about their values in
one study [44], but not in the other two studies [42, 48].
van Weert et al. BMC Medical Informatics and Decision Making  (2016) 16:45 Page 8 of 20
Table 2 Summary of findings attributes of the decision process: results in intervention group (IG) as compared with control group (CG) (n = 17)a
Short title Decisional conflictc Patient-provider communication Participation in decision making Satisfaction Other process
outcomes
Davison (1997) [28] n.m. n.m. More active role in treatment decision
making (assumed by participants)b
n.m. n.m.
Dolan (2002) [29] Less decisional conflict (total)b
In particular:
• No difference in uncertaintyb
• Better informedb
• Better clarity of valuesb
• More effective decision makingb
• No difference in supportb
n.m. Increase in SDM (vs no increase in
SDM in CG). Majority of patients
who preferred a SDM process felt
that the actual SDM process was
consistent with this preference
(vs half of the CG patients)b
n.m. n.m.
Fraenkel (2007) [30] n.m. n.m. Greater decisional self-efficacy
(i.e. self-confidence in abilities to
participate in SDM).
Greater preparedness to participate
in SDM.
Note: older adults (≥75) may be
among the most likely to benefit.
n.m. n.m.
Fraenkel (2012) [31] • Better informedb
• Better clarity of valuesb
More frequent discussion of risk of
stroke and risk of major bleeding.
n.m. n.m. n.m.




• More effective decision makingb
• Better score on “factors contributing
to uncertainty”b
Increased communication about
feeding options with providers
(i.e. more feeding discussions with
physician, nurse practitioner or
physician’s assistant). No differences
in discussions with other nursing
home staff.
Aa higher proportion felt involved in
feeding decisions (83 % vs 77 %) but
the difference was not significant.
No differences in satisfaction
with decision-making
n.m.
Jones (2009) [33] Less decisional conflict (total) when the
decision aid was delivered during the
visit by the clinician (IG2), but this
difference was not significant.
n.m. n.m. n.m. n.m.
Kaner (2007) [34] n.m. Duration: Computer-based decision
aids (IG1 and IG2) significantly
prolonged the consultations.
Non-verbal behavior: More nodding,
smiling and tool-directed gaze in
both IGs, and less head-shaking




No differences in decisional conflict
(total)b
In particular:
• No difference in uncertaintyb
• Better informedb
• No difference in clarity of valuesb
• No difference in effective decision
makingb
• No difference in supportb
n.m. No differences in participation in
decision makingb






















Table 2 Summary of findings attributes of the decision process: results in intervention group (IG) as compared with control group (CG) (n = 17)a (Continued)




• Better clarity of valuesb
• More effective decision makingb
• No difference in supportb
n.m. More autonomy in decision-making
about treatment (IG patient was
1.23 times more likely to make an
autonomous decision than CG
patient).
A smaller proportion in the IG
described their decision as
‘passive’ or ‘collaborative’.b
n.m. n.m.
Mathieu (2007) [37] No differences in total decisional
conflictb
In particular:
• No difference in uncertaintyb
• Better informedb
• Better clarity of valuesb
• No difference in effective decision
makingb
• No difference in supportb
n.m. n.m. n.m. No differences in
attitudes towards
screening.




• Better clarity of valuesb
• More effective decision making
(trend p = .09)b
• No difference in supportb
n.m. n.m. n.m. n.m.
Montori (2011) [39] No differences in decisional
conflict (total)b
n.m. Observed patient involvement
in SDM was approximately
double in IG than in CG.
No differences in satisfaction with
knowledge transfer (according to patients).
Greater satisfaction with knowledge
transfer in the IG group, particularly
‘helpfulness of the information’, ‘would
want other decisions’, ‘recommend to
others’ (according to clinicians).
Improved quality of the decision
making process, particularly
‘patients’ informed choice’,
‘provider expects patients to
stick with the decision’ and
‘provider believes patient is






Partin (2004) [40] n.m. IG2 (pamphlet) subjects were
more likely than controls to
discuss screening with their
provider, but IG1 (video)
subjects were not.
n.m. n.m. n.m.
Stirling (2012) [42] Less decisional conflict (total)
according to authors (however
not statistically significant, possibly
due to small sample size)b




















Table 2 Summary of findings attributes of the decision process: results in intervention group (IG) as compared with control group (CG) (n = 17)a (Continued)
In particular:
• No difference in uncertainty.
• No difference in feeling informed.
• No difference in clarity of values.
• No difference in effective decision
making.
• No difference in support.
Street (1995) [43] n.m. No difference between IG and CG
on patient-provider communication,
and no interaction between age/
education and intervention. In both
groups, college-educated patients
younger than 65 years of age were
more active participants in the
consultations than were older, less
educated patients (i.e. asked questions
more frequently, offered opinions, and
expressed concerns).
No difference in involvement in
decision making (self-reported)
and no interaction between
age/education and intervention.
n.m. n.m.
Thomson (2007) [44] Less decisional conflict (total)
immediately after the clinic.
In particular:
• No difference in uncertainty.
• Better informed.
• Better clarity of values.
• No difference in effective decision
making.
• No difference in support.
No difference in decisional conflict
subscales at three months.
n.m. n.m. n.m. n.m.
Weymiller (2007) [48] No significant differences in postvisit
decisional conflict (total).
In particular:
• No difference in uncertainty.
• Better informed, particularly when
the clinician delivered the
intervention during the visit (IG2).
• No difference in clarity of values.
• More effective decision making.
• No difference in support.
At 3 months, participants in the IG
continued to have less decisional
conflict than the IG, but these differences
were no longer statistically significant.
n.m. n.m. n.m. n.m.
n.m. = not measured; IG = intervention group; CG = control group; SDM = shared decision making
aUnless otherwise stated are the described results effects in the intervention group (IG) as compared to the control group (CG); see Additional file 2 for description of the CG intervention. Standard font indicates
positive results (p < .05 unless otherwise stated) in favour of the IG; italic font indicates no significant results
bIncluded in meta-analysis




















The MD for ‘uncertainty’ was −3.65 (95 % CI −9.54 to
2.23) in six studies that compared decision aids to usual
care (see Additional file 3 and Table 2). The three studies
that could not be pooled reported no difference [42, 44,
48].
The ‘feeling unsupported’ subscale was measured in
eight studies. In none of these there was a significant ef-
fect. MD was −1.30 (95 % CI −2.78 to 0.19) in five stud-
ies comparing decision aids to usual care (see Additional
file 3 and Table 2). There was no difference in the three
additional studies that could not be pooled [42, 44, 48].
Patient-provider communication Five studies reported
whether the intervention had an effect on patient-
provider communication. In one study, the decision aid
resulted in more frequent discussion about risk of stroke
and major bleeding [31]. Three studies described mixed
results, i.e., more communication about feeding options
with physician, nurse practitioner or physicians’ assistant,
but not with other nursing home staff [32], increased dis-
cussion of screening when using the pamphlet decision
aid (IG2), but not when using the video decision aid (IG1)
[40], positive effects on non-verbal communication, but
not on verbal communication, and a prolongation of con-
sultation duration [34]. The fifth study did not find posi-
tive effects of using a decision aid on patient-provider
communication in older (65+) with lower levels of educa-
tion. This study was the only study that looked at factors
associated with involvement in communication and re-
ported that younger (aged <65 years), higher educated pa-
tients were more active participants in the consultations
(i.e., asked more questions, offered more opinions, pro-
duced more expressions of concern and had more active
communication) than older, less educated patients, al-
though the older, less educated patients did not perceive
themselves as being less involved [43].
Participation in decision making Eight studies de-
scribed whether exposure to the decision aid had effects
on participation in decision making: of these, four stud-
ies that compared the effects of decision aids to usual
care using the Control Preferences Scale [51] could be
pooled (see Additional file 3 and Table 2). The Control
Preference Scale measures the role that the patient and
the physician can assume in decision making, ranging
from the patient selecting its own treatment through a
collaborative model to a scenario where the physician
alone makes the decision. The scale contains five re-
sponse statements: two describe an active (patient-con-
trolled) role, one a shared (collaborative) role, and two a
passive (practitioner-controlled) role. For patients adopt-
ing an active (patient-controlled) role in decision mak-
ing, the pooled RR for the four studies comparing
decision aids to usual care was 1.30 (95 % CI 0.86 to
1.95) (see Additional file 3 and Table 2). For patients
reporting a collaborative (shared decision making) role,
there was no difference between decision aid and usual
care (pooled RR 0.96; 95 % CI 0.82 to 1.13) (see Add-
itional file 3 and Table 2). An increase in patient partici-
pation in decision making can also be reflected by a
decrease in passive (practitioner-controlled) decision
making. When comparing the decision aid versus usual
care, a pooled RR of 0.61 (95 % CI 0.53 to 0.81) was
found (see Additional file 3 and Table 2). Two out of the
four additional studies that could not be pooled reported
positive effects, i.e., greater decisional self-efficacy and
preparedness to participate in decision making [30] and
significantly more intense patient involvement in decision
making according to video observations [39]. In the study
of Hanson et al. [32], the intervention group surrogates
felt more involved in feeding decisions than the control
group (83 % vs 77 %), but this difference did not reach sig-
nificance. In Street et al.’s study [43], patients’ perceptions
of control over decision-making did not differ between
groups or for patients differing in age and education.
Satisfaction In four studies, satisfaction with decision
making was assessed. In one study, ratings of the quality
of the decisions were higher in the intervention group
[29]. In three studies, there were no differences in satis-
faction with the decision making process [32, 35] or with
the knowledge transfer process (i.e., amount of informa-
tion, clarity of information, helpfulness of information,
would want other decisions, recommend-others) accord-
ing to patients [39]. However, in the latter study, clini-
cians expressed greater satisfaction with the knowledge
transfer process and with the quality of the decision
making process [39].
Other outcomes Mathieu et al. [37] found no differ-
ences in attitudes towards screening and Montori et al.
[39] no differences in trust in the clinician.
Behavior and health outcomes
The behavior and health outcomes that were reported in
the included studies were categorized in choice, adher-
ence with chosen option, preference-linked health out-
comes, health outcomes and health services outcomes.
Table 3 summarizes the results.
Choice or preference Choice respectively preference
was defined as the actual choice implemented respect-
ively the participants’ preferred option. Whether or not
the actual choice implemented is a ‘good’ choice can be
difficult to determine. IPDAS reached agreement on cri-
teria to judge “the things that you would need to observe
in order to say that after using a patient decision aid, the
way the decision was made was good and that the choice
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Table 3 Summary of findings behaviour and health outcomes: results in intervention group (IG) as compared with control group (CG) (n = 17)a
Short title Choice Adherence with chosen option Preference-linked health outcomes
(e.g. anxiety, depression, regret)
Health outcomes Health services
outcomes
Davison (1997) [28] n.m. n.m. Lower state anxiety levels at 6 weeks.
No differences in levels of depression
at 6 weeks.
n.m. n.m.
Dolan (2002) [29] No differences in decision (i.e. the proportion of
colorectal cancer screening plans carried out)b
n.m. n.m. n.m. n.m.
Fraenkel (2007) [30] n.m. n.m. Greater arthritis self-efficacy. n.m. n.m.
Fraenkel (2012) [31] A small proportion of the IG (n = 5) expressed
a preference for medication that was not
concordant with their current treatment plan.
No change in treatment plan.
n.m. No differences in anxiety.
No differences in worry about stroke
and about bleeding.
n.m. n.m.
Hanson (2011) [32] n.m. After 3 months: Residents in the IG had
greater use of some assisted oral feeding
techniques (i.e. were more likely to receive
a dysphagia diet and showed a trend
toward greater staff eating assistance).
No differences in tube feeding after 9 months.









More IG patients made a definite choice
about antithrombotic therapy (aspirin
or warfarin).
Slightly more IG patients preferred to
continue taking aspirin rather than switch
to warfarin.
A similar % of IG and CG reported that they,
rather than their physician, made the decision.
After 6 months: A similar % of IG and CG
continued to take the therapy that was
initially chosen.
n.m. n.m. n.m.
Mathers (2012) [36] No sign difference in proportion undecided
(although patients in IG were three times
more likely to change from undecided
to decided).




Mathieu (2007) [37] IG women were less likely to be undecided.
Among those women who made a decision,
there were no differences in intention to stop
or continue screening.
No differences in participation in screening.
n.m. No differences in anxiety.




After 3 months: Increase in the proportion
of patients receiving therapy appropriate
to their stroke risk (i.e. 12 % absolute
improvement in IG as compared to CG).
After 12 months: No difference in proportion
of patients taking appropriate therapy (i.e.
care in both IG and CG had regressed towards
baseline levels).
n.m. n.m. n.m.
Montori (2011) [39] No differences in distribution of prescriptions
(bisphosphonates were started by 44 % of IG
patients and 40 % of CG patients).
Adherence at 6 months was similarly high
across both groups (self-reported), but the
proportion with more than 80 % of days





















Table 3 Summary of findings behaviour and health outcomes: results in intervention group (IG) as compared with control group (CG) (n = 17)a (Continued)
Partin (2004) [40] IG1 and IG2 were less likely to intend to
have a PSA.
2 weeks post-target appointment: No
differences in PSA testing rates.
1 year post-target appointment: No differences
in PSA testing rates.
n.m. n.m. n.m.
Stirling (2012) [42] n.m. n.m. Less increase in carer burden (however
not statistically significant, possibly




Participants in the IG not already on warfarin
were much less likely to start warfarin than
participants not already on warfarin in
the CG.
n.m. There was a significant fall in anxiety
immediately after the clinic, but no













IG group was more likely to prefer comfort
care as their goal of care.
6 weeks after the intervention: IG had more
stable preferences over time.
Volandes (2011)
[47]
IG group was more likely to prefer comfort
care as their goal of care.
n.m. n.m. n.m. n.m.
Weymiller (2007)
[48]
30 % of IG patients and 21 % of CG patients
not receiving statin at baseline started statin
therapy immediately after the visit (not
reported whether this difference was
significant). IG patients with 10-year
cardiovascular risk greater than 15 %
most often started statin therapy.
Using the decision aid was not associated with stopping
statin therapy and was associated with greater
statin adherence at 3 months. Of 33 IG patients
taking statin drugs at 3 months, 2 reported
missing 1 dose or more in the last week
compared with 6 of 29 patients in the CG
group taking statin drugs.
Overall, there was no difference in adherence to
patient choice at 3 months.
n.m. n.m. n.m.
Wolf (2000) [49] No difference in screening interest between
the two IGs and the CGb
n.m. n.m. n.m. n.m.
n.m. = not measured; IG = intervention group; CG = control group
aUnless otherwise stated are the described results effects in the intervention group (IG) as compared to the control group (CG); see Additional file 2 for description of the CG intervention. Standard font indicates





















that was made was good” [12, page 7, based on 19–23].
This means that the chosen option can be considered ap-
propriate if the choice matches with what the informed
patient finds most important, and the decision aid can be
considered effective when decision aid usage improved
this match [12].
Fourteen studies reported whether exposure to the de-
cision aid resulted in differences in choice as compared
to the control group resp. usual care group. Only the
data for choice for colorectal cancer screening could be
pooled (see Additional file 3 and Table 3). Both two
studies on colorectal cancer screening reported no dif-
ference between the IG and usual care. The pooled RR
was 0.67 (95 % CI 0.18 to 2.54). Of the additional twelve
studies that could not be pooled, six only reported ef-
fects in favor of the intervention group [38, 44–48]. In
four studies, mixed results were described. Fraenkel et
al. [31] found no changes in actual treatment plan. Al-
though a small proportion of the intervention group
expressed a preference for medication (aspirin) that was
not in concordance with their current treatment plan
(warfarin), audiotapes of the consultations revealed that
these patients were convinced by their treating clinician
to continue taking warfarin. Man-Son-Hing et al. [35]
found no differences between the proportion partici-
pants in the intervention group and the control group
that felt they, rather than the physician, made the deci-
sion, but more intervention group patients than control
group patients made a definite choice about antithrom-
botic therapy (asparin or warfarin). As there was no
right or wrong choice of antithrombotic therapy, the
finding that the decision aid enhanced the patients’ abil-
ity to make choices regarding antithrombotic therapy
was considered as a positive effect. Although Mathieu et
al. [37] found that women in the intervention group
were less likely to be undecided than women in the con-
trol group, there were no differences in intention to stop
or continue screening and in participation in screening
among the women that made a decision. Partin et al.
[40] revealed that both intervention group participants
were less likely to intend to have prostate cancer screen-
ing than the control group participants. However, there
were no differences in actual PSA testing rates. In the
other two studies [36, 39] there were no significant dif-
ferences between the intervention and the control
groups in the decisions made. Mathers et al. [36] noted
that patients in the intervention group were over three
times more likely to change from undecided to decided
than in the control group, but this difference didn’t reach
significance.
Adherence with chosen option Seven studies measured
adherence with chosen option. One reported only posi-
tive effects [46]. Intervention group participants were
more likely to opt for comfort care as their preferred
goal of care and this preference was more stable over
time as compared with the control group. Two studies
had mixed findings. Hanson et al. [32] found that, after
three months, more assisted oral feeding techniques
were used in the intervention group as compared with
the control group, but after 9 months, there were no
longer any differences. In the study of Weymiller et al.
[48], there was no difference in adherence to choice
at three months. However, of 33 patients in the inter-
vention group taking statins at three months, two re-
ported missing one dose or more in the past week, as
compared to 6 out of 29 patients in the control
group, indicating higher medication adherence in the
intervention group. The other four studies found no
effects of the intervention after six months [35, 39] or
one year [38, 40].
Preference-linked health outcomes In seven studies,
preference-linked health outcomes, mainly anxiety or
worry, were assessed. One study found a positive effect
of using the decision aid on anxiety [28], but three other
studies did not found effectiveness on anxiety or worry
[31, 37, 44]. In one study, using the decision aid was
effective in increasing arthritis self-efficacy [30]. In
another study the intervention group of surrogates
has less increase in caregiver burden than the control
group [42], but this effect was not significant. No ef-
fectiveness was established on depression [28] or de-
cisional regret [32].
Health outcomes Three studies examined the effective-
ness of using the decision aid on health outcomes. In
the study of Hanson et al. [32], residents with demen-
tia had less weight loss after nine months, but there
were no differences in mortality. The other two studies
found no effects on glycaemic control [36] or strokes and
bleeds [44].
Health services outcomes Only one study investigated
health services outcomes. There were no differences in
General Practitioner consultations and hospital appoint-
ments [44].
IPDAS criteria
Additional file 4 shows the extent to which studies ad-
dressed issues considered important by International
Patient Decision aid Standards (IPDAS) [21, 22].
All decision aids evaluated in the included studies ful-
filled at least six IPDAS criteria. Eight IPDAS criteria
(i.e., IPDAS 1, 2, 3, 6, 7, 9, 10 and 25) were fulfilled in
90 % or more of the decision aids. All decision aids
(100 %) described the condition (health or other) related
to the decision (IPDAS-1) and the decision that needed
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to be considered (IPDAS-2), provided information about
the procedures involved (IPDAS-5), and, if dealing with
screening, information about what the test was designed
to measure (IPDAS-9) and possible next steps based on
the test results (IPDAS-10). Four criteria were fulfilled
in less than 25 % of the decision aids, i.e., information
about detection and treatment of disease that would
never have caused problems if screening had not been
done (IPDAS-12), the date when the decision aid was
last updated (IPDAS-26), whether authors of the decision
aid or their affiliations stand to gain or lose by choices
people make after using the decision aid (IPDAS-27) and
reporting of readability levels (IPDAS-28). Two important
criteria, i.e., whether value clarification was included
(IPDAS-17) and whether the decision aid made it possible
to compare the positive and negative features of the avail-
able options (IPDAS-18) were fulfilled in 68 % resp. 77 %
of the decision aids. Of the thirteen decision aids in which
probabilities were graphical presented, seven used the
same scale in each graph; in five decision aids this was un-
clear (IPDAS-16).
In five decision aids [28, 30, 36, 38, 43], between 25 %
and 50 % of the criteria were fulfilled. The other decision
aids fulfilled 50 % or more of the criteria, five (described
in seven papers) even more than 75 % [31, 33, 34, 37,
39, 44, 48]. No relationship could be found between the
fulfillment of the IPDAS criteria and the effectiveness of
the decision aid.
Risk of bias
Additional file 5 gives an overview of the risk of bias for
each individual paper, and the total risk of bias of in-
cluded studies. There was variability in potential risk of
bias across studies. The two criteria that were most often
problematic were lack of blinding of participants and
personnel (50 % no blinding and 32 % unclear) and the
potential for selective outcome reporting (86 % unclear).
Random sequence generation and providing complete
data was without risk of bias in the majority (77 %) of
the studies.
When looking at the individual papers, five had high
risk of bias, based on over five out of seven items being
unclear or judged with high risk [30, 36, 42, 43, 49]. In
one paper [44] there were no indications at all of risk of
bias. No relationship could be found between the risk of
bias and the effectiveness of the decision aid.
Discussion
This review shows promising results on the effectiveness
of decision aids for older adults. Decision aids have the
potential to increase older adults’ risk perception, improve
knowledge, decrease decisional conflict, and improve
patient participation in decision making by decreasing
practitioner-controlled decision making. Regarding
decisional conflict, particularly feelings of being informed,
clarity of values and effective decision making seemed to
improve.
These findings on knowledge, risk perception, deci-
sional conflict and participation in decision making are
in line with the results of the Cochrane review on the ef-
fectiveness of using a decision aids in a general popula-
tion [12], i.e., people of all ages. Hence, the results of the
Cochrane review seem to hold for older adults, although
the effects on knowledge and decisional conflict, espe-
cially regarding the subscales ‘feeling uninformed’ and
‘ineffective decision making’, are less strong than in the
Cochrane review (based on a comparison of the confi-
dence intervals; see Additional file 3). This indicates that
decision aids might be valuable tools for an older popu-
lation and suggests that decision aids have potential to
support older people’s information processing and deci-
sion making. However, there are a couple of concerns
that can be raised from the results. First, this review
shows that the body of literature on the effectiveness of
decision aids for older adults is still in its infancy. Next
to the relatively small number of papers that could be
included in this review and the heterogeneity of the
studies, only one paper explicitly stated that the decision
aid was developed for older adults [31]. In seven studies
(reported in eight papers), the mean age of the participants
was between 70 and 75 [30, 34, 37, 38, 44, 46, 47, 49], and
only one study reported that more than half of the partici-
pants was older than 75 [31]. In the other studies, the
mean age was below 70, which indicates that the oldest-
old (80+ year) were not included. Even though eleven of
the nineteen studies established a minimum age (ranging
from 50 to 70 years old) to be eligible for the study, it was
not clear for most of the decision aids whether or how the
decision aid was adapted to older adults’ abilities, needs or
preferences. Incorporating theory into the development,
design and evaluation of tools specifically designed to
support decision-making, may potentially lead to better
decision quality and outcomes [52]. This might especially
be important in research on older adults, as this group is
even more heterogeneous than the general population.
However, hardly any attention was paid to whether or not
the way of presenting choices was appropriate for older
adults. Older adults are expected to have more difficulties
in deliberative information processing, especially of factual
and statistical information, which might result in miscom-
prehensions [4]. Their decision making processes may
limit the amount and type of information they use and re-
duce their preferences for choice which has implications
for the likelihood that they will make a truly informed de-
cision. A person’s ability to use decision aids and partici-
pate in the decision making process will not only be
determined by their skills, but also by the quality and suit-
ability of the decision aids they have access to [53]. If
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designed age appropriately, decision aids could help com-
pensate for these difficulties. As the evidence is inconclu-
sive about how best to present information to older adults
[see for example 54–58], newly developed decision aids
should be carefully tested in the target group of older
people. Moreover, according to life-span developmental lit-
erature, older adults’ motivation to put efforts in decisions
depends on the perceived personal relevance of the deci-
sion and the person’s perceived self-efficacy. Improving
perceived relevance and building self-efficacy might there-
fore be crucial elements of medical decision making inter-
ventions for older adults [59].
Only few of the included studies in the review con-
ducted subgroup analysis in adults with low health liter-
acy or numeracy, low educated adults, frail patients or
other vulnerable (sub)groups. We therefore do not know
whether the decision aids under investigation were also
effective in these subgroups of older adults. In a recent
patient-level meta-analysis of seven randomized trials,
patients using a decision aid gained knowledge, were
more likely to know their risk, and had less decisional
conflict along with greater involvement in SDM compared
with usual care. These gains were largely consistent across
sociodemographic patient groups, with decision aids
demonstrating similar efficacy when used with vulner-
able patients such as the elderly and those with less in-
come and less formal education [60]. These results are
in conformity with the results of the current review, but
evidence on the efficacy of decision aids in vulnerable
groups is still scarce. If decision aids should be specific-
ally tailored to such groups, for example by including
appropriate visual illustrations (e.g., [61]) or animations
(e.g., [56]) this could lead to an even better impact out-
come in the decision making process. Although there
are good overviews of available decision aids, such as
The Ottawa Decision Aids Inventory gives, it is still un-
clear which formats are more or less applicable to older
adults. A first follow up step could be to conduct a lit-
erature review on studies focusing on the design, appli-
cation or evaluation of decision aids for older adults
using other designs than RCTs and CCTs, including
qualitative studies. This might help to identify existing
decision aids for older adults and might give more
insight whether there are more decision aids available
for this group than those evaluated in RCTs and CCTs
and whether these are designed age-appropriately. More-
over, it is recommended to tackle implementation strat-
egies for decision aids to be used by older adults. There
are already very relevant and useful Implementation
Toolkits available (e.g., on the website https://decisionai-
d.ohri.ca/). However, it is still unclear whether interven-
tions to improve adoption of SDM by health care
providers are effective given the low quality of the evi-
dence until now [62]. This certainly implies to
implementation strategies among older people. Future
research is needed to investigate which strategies work
best in an older population.
A limitation of the current review is that we included
studies using a sample with a mean age of 65 or older or
reporting effectiveness analysis of the decision aid in a
subsample of participants aged 65+ years. This means
that part of the participants was younger than 65. Eleven
of the nineteen studies used a cut-off point of at least
50 years to be eligible for the study. The other eight
studies used no cut-off point. Although using a mean
age may be misleading (e.g., if not normally distributed)
we did not choose for a cut-off point as inclusion criter-
ion. Our main aim was to investigate whether decision
aids are effective in an (on average) older population.
Given the lack of studies with a primary focus on the
elderly, we also wanted to include studies that were con-
ducted in an on average older population without a con-
scious focus on the elderly. In fact, the decision aids
under investigation in the eight studies not using a cut-
off point were aimed at improving decision making in
treatment, screening or care decisions regarding diseases
that are very common among older people, such as type
II diabetes mellitus [33, 36, 48], atrial fibrillation [31, 35,
38], dementia [42] and prostate cancer screening [28]. In
our opinion the results of these studies contributed to
fulfilling the study goals.
Another limitation of this review is that we were not
able to analyze the underlying evidence, and whether or
not this evidence was appropriate for older people,
which was unclear in most studies. We know from lit-
erature that evidence for many interventions in the older
population is scarce, especially those with functional im-
pairments and multi-morbidity [63]. We therefore ex-
pect that most decision aids did not tailor the evidence
to this group. It is doubtful whether it will ever be pos-
sible to provide relevant and evidence based information
tailored to all possible combinations of comorbidities in
a single decision aid. This indicates that decision aids for
older adults might be most effective when combined
with high quality patient-provider interaction during
consultation, with personal tailoring of the decision aid
to the individual persons’ context. Although less often
studied, the findings of this review indicate that decision
aids have the potential to be effective in improving older
adults’ participation in decision making and might im-
prove patient-provider communication. Furthermore, it
was found that patient outcomes were better when par-
ticipants received the decision aid from their clinician
during the consultation than when it was delivered by
the researcher before the consultation [33, 48]. We also
know that the health care provider is still the most im-
portant source of information for most older patients
[64], and although some studies indicate that older
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adults have a preference for less participation in shared
decision making than younger ones [65–67], other re-
search shows that the majority of people, including older
adults, want to be involved in the decision making process
[10]. This suggests that decision aids might be particularly
useful for older adults when successfully integrated with
interpersonal communication in the consultation. There
were only two other studies, described in three papers, in
which the decision aid was delivered during the consult-
ation [34, 39, 44], one of them using a trained research
GP, so not the patients’ own GP [34, 44]. It is therefore
recommended to study the added value of decision aids,
delivered by the provider during the consultation, on com-
munication during consultation in future research.
Last, there are some methodological limitations. Several
outcome measurements are not validated for older adults.
Moreover, there is little guidance on how to best assess
outcomes measures such as knowledge and risk percep-
tion in decision aid trials. Few trials explicitly describe
how these measures were developed. Furthermore, al-
though most studies showed no risk of bias regarding
random sequence generation and providing complete out-
come data, there was a high risk of bias in more than 80 %
of the studies with regard to blinding of participants and
personnel and selective reporting. This is in line with the
Cochrane review on the effectiveness of decision aids [12].
It is recommended to further diminish the risk of bias in
future RCTs, particularly with regard to reporting bias.
Conclusions
To conclude, the results of the current review indicate
that decision aids can be effective for older adults. The
decision aids increased their knowledge and risk percep-
tion, decreased decisional conflict and seemed to enhance
participation in decision making. Further improvements
can be made by a structured development and evaluation
of those interventions among more heterogeneous groups
of older adults. In particular, individualizing of decision
aids to the heterogeneity and functional impairments of
the oldest-old with, for instance, multi-morbidity and lim-
ited health literacy forms a challenge.
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